AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
188,50 € ↑0,35 (0,19%)
2026-06-04
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionAspiriant, Llc
Latest Disclosed Ownership9,735 shares
Latest Disclosed Value $ 2,117,265
Aspiriant, Llc reports 3.10% increase in ownership of 4AB / AbbVie Inc.

On May 12, 2026 - Aspiriant, Llc filed a 13F-HR form disclosing ownership of 9,735 shares of AbbVie Inc. (DE:4AB) valued at $1,804,869 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 9,442 shares of AbbVie Inc.. This represents a change in shares of 3.10% during the quarter. The current value of the position is $1,835,048 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ABBVIE COM 00287Y109 9,735 293 3.10 2,117 -1.85 0.0603
2026-01-20 2025-12-31 13F ABBVIE COM 00287Y109 9,442 207 2.24 2,157 0.89 0.0620
2025-10-24 2025-09-30 13F ABBVIE COM 00287Y109 9,235 839 9.99 2,138 37.23 0.0654
2025-07-29 2025-06-30 13F ABBVIE COM 00287Y109 8,396 -107 -1.26 1,558 -12.52 0.0495
2025-04-21 2025-03-31 13F ABBVIE COM 00287Y109 8,503 -274 -3.12 1,782 14.24 0.0618
2025-01-16 2024-12-31 13F ABBVIE COM 00287Y109 8,777 412 4.93 1,560 -5.57 0.0563
2024-10-17 2024-09-30 13F ABBVIE COM 00287Y109 8,365 -133 -1.57 1,652 13.32 0.0627
2024-07-15 2024-06-30 13F ABBVIE COM 00287Y109 8,498 -767 -8.28 1,458 -13.63 0.0594
2024-04-15 2024-03-31 13F ABBVIE COM 00287Y109 9,265 260 2.89 1,687 20.93 0.0698
2024-01-26 2023-12-31 13F ABBVIE COM 00287Y109 9,005 -216 -2.34 1,396 1.53 0.0628
2023-10-18 2023-09-30 13F ABBVIE COM 00287Y109 9,221 -26 -0.28 1,374 10.36 0.0703
2023-07-19 2023-06-30 13F ABBVIE COM 00287Y109 9,247 379 4.27 1,246 -11.89 0.0630
2023-04-27 2023-03-31 13F ABBVIE COM 00287Y109 8,868 384 4.53 1,413 3.06 0.0740
2023-01-23 2022-12-31 13F ABBVIE COM 00287Y109 8,484 502 6.29 1,371 28.01 0.0699
2022-10-28 2022-09-30 13F ABBVIE COM 00287Y109 7,982 -8,632 -51.96 1,071 -57.88 0.0524
2022-07-25 2022-06-30 13F ABBVIE COM 00287Y109 16,614 55 0.33 2,543 -5.22 0.1227
2022-05-06 2022-03-31 13F ABBVIE COM 00287Y109 16,559 8,999 119.03 2,683 162.27 0.1475
2022-02-14 2021-12-31 13F ABBVIE COM 00287Y109 7,560 227 3.10 1,023 29.33 0.0547
2021-10-27 2021-09-30 13F ABBVIE COM 00287Y109 7,333 -6 -0.08 791 -4.35 0.0465
2021-08-13 2021-06-30 13F ABBVIE COM 00287Y109 7,339 -74 -1.00 827 3.25 0.0468
2021-05-11 2021-03-31 13F ABBVIE COM 00287Y109 7,413 768 11.56 801 12.82 0.0512
2021-02-01 2020-12-31 13F ABBVIE COM 00287Y109 6,645 169 2.61 710 25.44 0.0484
2020-10-29 2020-09-30 13F ABBVIE COM 00287Y109 6,476 -5 -0.08 566 -11.01 0.0443
2020-08-06 2020-06-30 13F ABBVIE COM 00287Y109 6,481 -74 -1.13 636 27.45 0.0591
2020-05-05 2020-03-31 13F ABBVIE COM 00287Y109 6,555 1,176 21.86 499 5.05 0.0491
2020-01-27 2019-12-31 13F ABBVIE COM 00287Y109 5,379 -264 -4.68 475 10.98 0.0440
2019-11-04 2019-09-30 13F ABBVIE COM 00287Y109 5,643 1,970 53.63 428 59.70 0.0383
2019-08-06 2019-06-30 13F ABBVIE COM 00287Y109 3,673 0 0.00 268 -9.15 0.0224
2019-08-06 2019-03-31 13F/A-1 ABBVIE COM 00287Y109 3,673 -1,988 -35.12 295 -43.38 0.0241
2019-05-03 2019-03-31 13F ABBVIE COM 00287Y109 3,673 -1,988 295
2019-02-04 2018-12-31 13F ABBVIE COM 00287Y109 5,661 -173 -2.97 521 -5.62 0.0395
2018-10-26 2018-09-30 13F ABBVIE COM 00287Y109 5,834 -651 -10.04 552 -8.15 0.0472
2018-08-07 2018-06-30 13F ABBVIE COM 00287Y109 6,485 45 0.70 601 -1.48 0.0515
2018-05-04 2018-03-31 13F ABBVIE COM 00287Y109 6,440 6,440 610 0.0532
2018-01-31 2017-12-31 13F ABBVIE COM 00287Y109 0 -4,262 -100.00 0 -100.00
2017-11-13 2017-09-30 13F ABBVIE COM 00287Y109 4,262 -184 -4.14 379 17.70 0.0318
2017-08-03 2017-06-30 13F ABBVIE COM 00287Y109 4,446 4,446 322 0.0280
2016-11-10 2016-09-30 13F ABBVIE COM 00287Y109 0 -3,905 -100.00 0 -100.00
2016-08-09 2016-06-30 13F ABBVIE COM 00287Y109 3,905 3,905 261 0.0247
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.